CN Stock MarketDetailed Quotes

301258 Suzhou Fushilai Pharmaceutical

Watchlist
  • 25.02
  • -1.23-4.69%
Market Closed Aug 9 15:00 CST
2.29BMarket Cap34.56P/E (TTM)

Suzhou Fushilai Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-38.47%96.29M
-13.89%489.29M
-2.35%388.63M
9.17%297.35M
10.38%156.49M
8.92%568.21M
12.86%397.98M
5.79%272.36M
23.23%141.78M
9.40%521.7M
Operating revenue
-38.47%96.29M
-13.89%489.29M
-2.35%388.63M
9.17%297.35M
10.38%156.49M
8.92%568.21M
12.86%397.98M
5.79%272.36M
23.23%141.78M
9.40%521.7M
Other operating revenue
----
-67.86%6.19M
----
-63.02%4.89M
----
92.00%19.26M
----
148.29%13.23M
----
0.47%10.03M
Total operating cost
-11.56%93.17M
5.89%389.09M
12.02%288.66M
14.84%202.17M
2.67%105.35M
-4.75%367.44M
0.24%257.68M
-4.65%176.04M
21.75%102.61M
21.03%385.74M
Operating cost
-11.93%73.94M
-3.15%301.38M
0.84%224.54M
8.46%161.52M
4.21%83.95M
-0.11%311.18M
7.98%222.66M
-0.64%148.92M
16.48%80.55M
23.88%311.51M
Operating tax surcharges
-44.37%933.72K
6.13%5.41M
24.12%4.55M
17.38%3.38M
8.18%1.68M
24.12%5.1M
17.56%3.67M
45.87%2.88M
61.19%1.55M
-3.98%4.11M
Operating expense
-6.86%1.07M
10.10%4.89M
9.98%3.69M
12.27%2.31M
-2.55%1.15M
-5.47%4.44M
-7.62%3.35M
-14.57%2.06M
1.49%1.18M
-23.00%4.7M
Administration expense
-12.19%8.82M
6.46%46M
5.37%33.29M
5.31%22.66M
3.27%10.05M
31.98%43.2M
32.48%31.59M
45.77%21.52M
35.51%9.73M
12.03%32.74M
Financial expense
-315.57%-2.9M
75.45%-9.29M
77.13%-7.96M
65.12%-6.88M
-184.23%-698.55K
-1,007.46%-37.86M
-31,508.21%-34.79M
-1,658.72%-19.71M
145.38%829.37K
-12.75%4.17M
-Interest expense (Financial expense)
-19.97%25.17K
-62.09%116.46K
-64.30%89.69K
-75.58%61.35K
-82.27%31.45K
-31.74%307.22K
-6.51%251.21K
187.51%251.21K
--177.39K
--450.04K
-Interest Income (Financial expense)
-41.31%-2.33M
-20.15%-8.11M
-31.99%-5.66M
-22.10%-3.85M
-141.59%-1.65M
-239.36%-6.75M
-259.75%-4.29M
-341.18%-3.16M
-161.73%-681.21K
-25.42%-1.99M
Research and development
22.63%11.31M
-1.61%40.7M
-2.08%30.55M
-5.90%19.17M
5.18%9.23M
45.08%41.37M
53.24%31.19M
41.97%20.37M
14.70%8.77M
24.65%28.51M
Credit Impairment Loss
-115.41%-127.51K
441.99%1.17M
51.08%1.19M
101.34%508.37K
248.89%827.37K
15.90%-342.52K
-23.78%786.75K
89.69%252.49K
-159.17%-555.68K
-195.12%-407.27K
Asset Impairment Loss
-36.76%-274.76K
104.31%160.29K
1.96%2.14M
14.60%2.16M
---200.9K
-36.15%-3.72M
542.12%2.1M
12,586.91%1.88M
----
-287.14%-2.73M
Other net revenue
-65.45%3.14M
577.39%33.42M
223.62%26.07M
112.54%17.16M
23.55%9.08M
-12.99%4.93M
24.02%8.06M
139.20%8.07M
152.38%7.35M
-49.99%5.67M
Fair value change income
-300.50%-5.17M
833.09%6.31M
143.80%5.7M
115.45%1.01M
330.10%2.58M
-153.35%-860.99K
-1,900.15%-13M
-45,392.83%-6.54M
--598.95K
246.84%1.61M
Invest income
48.16%7.27M
1,332.26%20.86M
44.35%14.11M
111.30%11.73M
313.20%4.91M
-44.65%1.46M
484.48%9.77M
255.07%5.55M
13.44%1.19M
-65.98%2.63M
Asset deal income
----
---392.26K
----
----
----
----
----
----
----
----
Other revenue
47.36%1.44M
-36.77%5.31M
-65.00%2.94M
-74.65%1.76M
-84.08%974.56K
84.02%8.4M
136.95%8.4M
312.44%6.93M
559.83%6.12M
-8.34%4.57M
Operating profit
-89.61%6.26M
-35.04%133.62M
-15.04%126.04M
7.60%112.34M
29.48%60.23M
45.25%205.71M
45.32%148.36M
36.99%104.4M
38.11%46.52M
-16.43%141.62M
Add:Non operating Income
329.63%2.32K
4.29%47.4K
80.29%1.97K
55.12%760.11
38.46%540
2,033.81%45.45K
-36.99%1.09K
58.06%490
3,800.00%390
-98.19%2.13K
Less:Non operating expense
-37.01%280.06K
55.51%5.12M
19.16%2.21M
5.02%693.87K
142.29%444.6K
3.56%3.3M
-32.75%1.85M
-67.68%660.72K
-90.84%183.5K
-33.09%3.18M
Total profit
-90.00%5.98M
-36.51%128.54M
-15.48%123.83M
7.62%111.65M
29.03%59.79M
46.24%202.46M
47.48%146.51M
39.87%103.74M
46.27%46.34M
-16.01%138.44M
Less:Income tax cost
-97.64%192.68K
-34.95%16.36M
-13.88%16.68M
11.38%15.3M
27.50%8.18M
37.89%25.15M
47.23%19.37M
22.81%13.74M
33.77%6.42M
-23.28%18.24M
Net profit
-88.79%5.79M
-36.73%112.18M
-15.72%107.15M
7.05%96.34M
29.28%51.61M
47.51%177.31M
47.52%127.13M
42.90%90M
48.50%39.92M
-14.78%120.2M
Net profit from continuing operation
-88.79%5.79M
-36.73%112.18M
-15.72%107.15M
7.05%96.34M
29.28%51.61M
47.51%177.31M
47.52%127.13M
42.90%90M
48.50%39.92M
-14.78%120.2M
Net profit of parent company owners
-88.79%5.79M
-36.73%112.18M
-15.72%107.15M
7.05%96.34M
29.28%51.61M
47.51%177.31M
47.52%127.13M
42.90%90M
48.50%39.92M
-14.78%120.2M
Earning per share
Basic earning per share
-88.79%0.0631
-40.78%1.22
-22.74%1.1689
-6.34%1.051
-2.93%0.563
17.71%2.06
20.70%1.513
22.49%1.1221
48.72%0.58
-14.63%1.75
Diluted earning per share
-88.79%0.0631
-40.78%1.22
-22.74%1.1689
-6.34%1.051
-2.93%0.563
17.71%2.06
20.70%1.513
22.49%1.1221
48.72%0.58
-14.63%1.75
Other composite income
Total composite income
-88.79%5.79M
-36.73%112.18M
-15.72%107.15M
7.05%96.34M
29.28%51.61M
47.51%177.31M
47.52%127.13M
42.90%90M
48.50%39.92M
-14.78%120.2M
Total composite income of parent company owners
-88.79%5.79M
-36.73%112.18M
-15.72%107.15M
7.05%96.34M
29.28%51.61M
47.51%177.31M
47.52%127.13M
42.90%90M
48.50%39.92M
-14.78%120.2M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -38.47%96.29M-13.89%489.29M-2.35%388.63M9.17%297.35M10.38%156.49M8.92%568.21M12.86%397.98M5.79%272.36M23.23%141.78M9.40%521.7M
Operating revenue -38.47%96.29M-13.89%489.29M-2.35%388.63M9.17%297.35M10.38%156.49M8.92%568.21M12.86%397.98M5.79%272.36M23.23%141.78M9.40%521.7M
Other operating revenue -----67.86%6.19M-----63.02%4.89M----92.00%19.26M----148.29%13.23M----0.47%10.03M
Total operating cost -11.56%93.17M5.89%389.09M12.02%288.66M14.84%202.17M2.67%105.35M-4.75%367.44M0.24%257.68M-4.65%176.04M21.75%102.61M21.03%385.74M
Operating cost -11.93%73.94M-3.15%301.38M0.84%224.54M8.46%161.52M4.21%83.95M-0.11%311.18M7.98%222.66M-0.64%148.92M16.48%80.55M23.88%311.51M
Operating tax surcharges -44.37%933.72K6.13%5.41M24.12%4.55M17.38%3.38M8.18%1.68M24.12%5.1M17.56%3.67M45.87%2.88M61.19%1.55M-3.98%4.11M
Operating expense -6.86%1.07M10.10%4.89M9.98%3.69M12.27%2.31M-2.55%1.15M-5.47%4.44M-7.62%3.35M-14.57%2.06M1.49%1.18M-23.00%4.7M
Administration expense -12.19%8.82M6.46%46M5.37%33.29M5.31%22.66M3.27%10.05M31.98%43.2M32.48%31.59M45.77%21.52M35.51%9.73M12.03%32.74M
Financial expense -315.57%-2.9M75.45%-9.29M77.13%-7.96M65.12%-6.88M-184.23%-698.55K-1,007.46%-37.86M-31,508.21%-34.79M-1,658.72%-19.71M145.38%829.37K-12.75%4.17M
-Interest expense (Financial expense) -19.97%25.17K-62.09%116.46K-64.30%89.69K-75.58%61.35K-82.27%31.45K-31.74%307.22K-6.51%251.21K187.51%251.21K--177.39K--450.04K
-Interest Income (Financial expense) -41.31%-2.33M-20.15%-8.11M-31.99%-5.66M-22.10%-3.85M-141.59%-1.65M-239.36%-6.75M-259.75%-4.29M-341.18%-3.16M-161.73%-681.21K-25.42%-1.99M
Research and development 22.63%11.31M-1.61%40.7M-2.08%30.55M-5.90%19.17M5.18%9.23M45.08%41.37M53.24%31.19M41.97%20.37M14.70%8.77M24.65%28.51M
Credit Impairment Loss -115.41%-127.51K441.99%1.17M51.08%1.19M101.34%508.37K248.89%827.37K15.90%-342.52K-23.78%786.75K89.69%252.49K-159.17%-555.68K-195.12%-407.27K
Asset Impairment Loss -36.76%-274.76K104.31%160.29K1.96%2.14M14.60%2.16M---200.9K-36.15%-3.72M542.12%2.1M12,586.91%1.88M-----287.14%-2.73M
Other net revenue -65.45%3.14M577.39%33.42M223.62%26.07M112.54%17.16M23.55%9.08M-12.99%4.93M24.02%8.06M139.20%8.07M152.38%7.35M-49.99%5.67M
Fair value change income -300.50%-5.17M833.09%6.31M143.80%5.7M115.45%1.01M330.10%2.58M-153.35%-860.99K-1,900.15%-13M-45,392.83%-6.54M--598.95K246.84%1.61M
Invest income 48.16%7.27M1,332.26%20.86M44.35%14.11M111.30%11.73M313.20%4.91M-44.65%1.46M484.48%9.77M255.07%5.55M13.44%1.19M-65.98%2.63M
Asset deal income -------392.26K--------------------------------
Other revenue 47.36%1.44M-36.77%5.31M-65.00%2.94M-74.65%1.76M-84.08%974.56K84.02%8.4M136.95%8.4M312.44%6.93M559.83%6.12M-8.34%4.57M
Operating profit -89.61%6.26M-35.04%133.62M-15.04%126.04M7.60%112.34M29.48%60.23M45.25%205.71M45.32%148.36M36.99%104.4M38.11%46.52M-16.43%141.62M
Add:Non operating Income 329.63%2.32K4.29%47.4K80.29%1.97K55.12%760.1138.46%5402,033.81%45.45K-36.99%1.09K58.06%4903,800.00%390-98.19%2.13K
Less:Non operating expense -37.01%280.06K55.51%5.12M19.16%2.21M5.02%693.87K142.29%444.6K3.56%3.3M-32.75%1.85M-67.68%660.72K-90.84%183.5K-33.09%3.18M
Total profit -90.00%5.98M-36.51%128.54M-15.48%123.83M7.62%111.65M29.03%59.79M46.24%202.46M47.48%146.51M39.87%103.74M46.27%46.34M-16.01%138.44M
Less:Income tax cost -97.64%192.68K-34.95%16.36M-13.88%16.68M11.38%15.3M27.50%8.18M37.89%25.15M47.23%19.37M22.81%13.74M33.77%6.42M-23.28%18.24M
Net profit -88.79%5.79M-36.73%112.18M-15.72%107.15M7.05%96.34M29.28%51.61M47.51%177.31M47.52%127.13M42.90%90M48.50%39.92M-14.78%120.2M
Net profit from continuing operation -88.79%5.79M-36.73%112.18M-15.72%107.15M7.05%96.34M29.28%51.61M47.51%177.31M47.52%127.13M42.90%90M48.50%39.92M-14.78%120.2M
Net profit of parent company owners -88.79%5.79M-36.73%112.18M-15.72%107.15M7.05%96.34M29.28%51.61M47.51%177.31M47.52%127.13M42.90%90M48.50%39.92M-14.78%120.2M
Earning per share
Basic earning per share -88.79%0.0631-40.78%1.22-22.74%1.1689-6.34%1.051-2.93%0.56317.71%2.0620.70%1.51322.49%1.122148.72%0.58-14.63%1.75
Diluted earning per share -88.79%0.0631-40.78%1.22-22.74%1.1689-6.34%1.051-2.93%0.56317.71%2.0620.70%1.51322.49%1.122148.72%0.58-14.63%1.75
Other composite income
Total composite income -88.79%5.79M-36.73%112.18M-15.72%107.15M7.05%96.34M29.28%51.61M47.51%177.31M47.52%127.13M42.90%90M48.50%39.92M-14.78%120.2M
Total composite income of parent company owners -88.79%5.79M-36.73%112.18M-15.72%107.15M7.05%96.34M29.28%51.61M47.51%177.31M47.52%127.13M42.90%90M48.50%39.92M-14.78%120.2M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg